search
Back to results

Assessment of Cystic Fibrosis Lung Involvement With UTE Pulse Sequences (MucoIRM)

Primary Purpose

Cystic Fibrosis

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
MR measurements of lung morphological changes in cystic fibrosis (Avanto dot, Siemens)
CT measurements of lung morphological changes in cystic fibrosis
Sponsored by
University Hospital, Bordeaux
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Cystic Fibrosis focused on measuring Cystic fibrosis, MRI, UTE, CT, Exacerbation, Quality of life, Pulmonary function

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • cystic fibrosis adults
  • written informed consent

Exclusion Criteria:

  • Subjects without any social security or health insurance
  • Pregnancy
  • MRI contraindications: Magnetically activated implanted devices (cardiac pacemakers, insulin pumps, neurostimulators, cochlear implants), metal inside the eye or the brain (aneurysm clip, ocular foreign body), cardiac valvular prosthesis (Starr-Edwards pre-6000), subject with claustrophobia.

Sites / Locations

  • University Hospital Bordeaux

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Cystic fibrosis adults

Arm Description

Outcomes

Primary Outcome Measures

Agreement between MRI and CT for scoring lung involvement in cystic fibrosis
MRI and CT evaluation of lung lesions quantification in cystic fibrosis will be assessed by 2 blind radiologists. Agreement between both evaluation will be assessed during statistical analyses after study completion.

Secondary Outcome Measures

Cystic fibrosis lesions scoring extracted from CT and MR images
MRI and CT evaluation of lung lesions quantification in cystic fibrosis will be assessed by 2 blind radiologists. Agreement between both evaluation will be assessed during statistical analyses after study completion.
MRI cystic fibrosis reproductibility scoring over the time
MRI cystic fibrosis scoring will be assessed a second time the same blind radiologist
Correlation between MRI cystic fibrosis scoring and PFT indexes
Correlation between MRI cystic fibrosis scoring and exacerbation number
Correlation between MRI cystic fibrosis scoring and quality of life
Evolution of MRI cystic fibrosis scoring after one year

Full Information

First Posted
May 13, 2015
Last Updated
November 23, 2017
Sponsor
University Hospital, Bordeaux
search

1. Study Identification

Unique Protocol Identification Number
NCT02449785
Brief Title
Assessment of Cystic Fibrosis Lung Involvement With UTE Pulse Sequences
Acronym
MucoIRM
Official Title
Assessment of Lung Involvement in Cystic Fibrosis Patients Using 1.5T MR Imaging With Ultrashort Echo Time (UTE) Pulse Sequences
Study Type
Interventional

2. Study Status

Record Verification Date
November 2017
Overall Recruitment Status
Completed
Study Start Date
September 30, 2015 (Actual)
Primary Completion Date
September 6, 2016 (Actual)
Study Completion Date
September 6, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Bordeaux

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Non-invasive assessment of lung involvement is a crucial issue for the follow-up of cystic fibrosis patients. Currently, CT is the method of reference to evaluate and quantify the lung morphological changes in cystic fibrosis adults but it remains a radiation-based technique. MRI with ultrashort echo time (UTE) pulse sequences is a promising non-ionizing alternative for lung imaging. The investigators' objective is to evaluate cystic fibrosis lung involvement using CT and MRI-UTE, and to test the agreement between both techniques.
Detailed Description
Cystic fibrosis is a recessive autosomic fatal disease, affecting about 6000 people in France. Thanks to progress in symptomatic care, median survival is increasing. The lung involvement is the most common and responsible for most deaths. The evaluation of respiratory disease severity is based on pulmonary functional tests (PFT) and imaging. Multi-slice computed tomography (CT) is the method of reference to quantify lung involvement in cystic fibrosis. It detects respiratory lung involvement earlier than PFT, and it reveals lesions associated with the onset of respiratory exacerbations, the mortality increase and the reduction of quality of life. However CT provides ionizing radiation, thus limiting the possibility of long-term follow-up. MRI is a non-ionizing 3D imaging technique; nevertheless, lung MRI is technically challenging with the result that it is currently not used in routine practice. Indeed, both low proton density and susceptibility effects lead to very low signal intensity derived from lung parenchyma. Recently, pulse sequences with ultrashort echo time (UTE) have been implemented by the use of half radio-frequency excitations and radial projection reconstruction. These UTE sequences make it theoretically possible to retrieve more signal from the lung parenchyma. The investigators aim at using 3D T1-weighted UTE pulse sequences on a 1.5T magnet (Avanto dot, Siemens) in cystic fibrosis patients in order to assess lung involvement severity. Thirty three cystic fibrosis adults are expected to take part in the study. All will benefit from PFT, CT and MRI. The investigators' strategy is to establish a semi quantitative score of pulmonary severity (Helbich score) using MRI and CT in subjects, testing for correlations between MRI and CT measurements and assessing the reproducibility of lung lesions quantification using MRI. The investigators' objective is to demonstrate that MRI-UTE pulse sequence at 1.5T is accurate and reproducible in evaluating and quantifying pulmonary involvement in cystic fibrosis.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cystic Fibrosis
Keywords
Cystic fibrosis, MRI, UTE, CT, Exacerbation, Quality of life, Pulmonary function

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
30 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Cystic fibrosis adults
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
MR measurements of lung morphological changes in cystic fibrosis (Avanto dot, Siemens)
Intervention Type
Device
Intervention Name(s)
CT measurements of lung morphological changes in cystic fibrosis
Primary Outcome Measure Information:
Title
Agreement between MRI and CT for scoring lung involvement in cystic fibrosis
Description
MRI and CT evaluation of lung lesions quantification in cystic fibrosis will be assessed by 2 blind radiologists. Agreement between both evaluation will be assessed during statistical analyses after study completion.
Time Frame
During MRI and CT, Day one
Secondary Outcome Measure Information:
Title
Cystic fibrosis lesions scoring extracted from CT and MR images
Description
MRI and CT evaluation of lung lesions quantification in cystic fibrosis will be assessed by 2 blind radiologists. Agreement between both evaluation will be assessed during statistical analyses after study completion.
Time Frame
During MRI and CT, Day one
Title
MRI cystic fibrosis reproductibility scoring over the time
Description
MRI cystic fibrosis scoring will be assessed a second time the same blind radiologist
Time Frame
During MRI, Day one
Title
Correlation between MRI cystic fibrosis scoring and PFT indexes
Time Frame
Day one
Title
Correlation between MRI cystic fibrosis scoring and exacerbation number
Time Frame
12 month after Day one
Title
Correlation between MRI cystic fibrosis scoring and quality of life
Time Frame
Day one and 12 month after Day one
Title
Evolution of MRI cystic fibrosis scoring after one year
Time Frame
12 month after Day one

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: cystic fibrosis adults written informed consent Exclusion Criteria: Subjects without any social security or health insurance Pregnancy MRI contraindications: Magnetically activated implanted devices (cardiac pacemakers, insulin pumps, neurostimulators, cochlear implants), metal inside the eye or the brain (aneurysm clip, ocular foreign body), cardiac valvular prosthesis (Starr-Edwards pre-6000), subject with claustrophobia.
Facility Information:
Facility Name
University Hospital Bordeaux
City
Pessac
Country
France

12. IPD Sharing Statement

Citations:
PubMed Identifier
32415586
Citation
Benlala I, Point S, Leung C, Berger P, Woods JC, Raherison C, Laurent F, Macey J, Dournes G. Volumetric quantification of lung MR signal intensities using ultrashort TE as an automated score in cystic fibrosis. Eur Radiol. 2020 Oct;30(10):5479-5488. doi: 10.1007/s00330-020-06910-w. Epub 2020 May 15.
Results Reference
derived

Learn more about this trial

Assessment of Cystic Fibrosis Lung Involvement With UTE Pulse Sequences

We'll reach out to this number within 24 hrs